日本新薬(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4516/E00931-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2017/07/21日証協無担保0株-100%0株0%1株-99%
2017/07/21日証協有担保24,771株-83%6,046株-50.11%12,600株-79.05%
2017/07/14日証協無担保500株-90%0株0%100株-93.33%
2017/07/14日証協有担保145,685株-42.05%12,118株+707.87%60,131株+16.85%
2017/07/07日証協無担保5,000株-89.13%0株-100%1,500株+1400%
2017/07/07日証協有担保251,390株+36.09%1,500株-95.1%51,458株-66.63%
2017/06/30日証協無担保46,000株+2321.05%8,000株+37.93%100株-3.85%
2017/06/30日証協有担保184,729株-1.51%30,613株+24.47%154,200株+273.37%
2017/06/23日証協無担保1,900株0%5,800株+262.5%104株-99.47%
2017/06/23日証協有担保187,555株+130.92%24,595株+2057.46%41,300株+35.42%
2017/06/16日証協無担保0株-100%1,600株-30.43%19,800株+9800%
2017/06/16日証協有担保81,222株+36.42%1,140株-18.57%30,497株-19.91%
2017/06/09日証協無担保20,000株0%2,300株-43.9%200株-33.33%
2017/06/09日証協有担保59,539株-52.72%1,400株-95.14%38,080株-58.38%
2017/06/02日証協無担保0株-100%4,100株0%300株-3.23%
2017/06/02日証協有担保125,923株-38.17%28,779株+1006.88%91,500株+2.81%
2017/05/26日証協無担保1,800株0%0株-100%310株-38.12%
2017/05/26日証協有担保203,644株+7.35%2,600株-90.23%89,000株-26.3%
2017/05/19日証協無担保0株0%4,500株-62.18%501株+150.5%
2017/05/19日証協有担保189,693株+87.83%26,604株+1993.15%120,754株+76.37%
2017/05/12日証協無担保0株0%11,900株0%200株-97.59%
2017/05/12日証協有担保100,993株+96.08%1,271株-87.19%68,468株+734.98%
2017/05/02日証協無担保0株0%0株0%8,300株+822.22%
2017/05/02日証協有担保51,505株-73.29%9,919株+608.5%8,200株-90.44%
2017/04/28日証協無担保0株0%0株-100%900株0%
2017/04/28日証協有担保192,812株+600.42%1,400株+40%85,800株+420%
2017/04/21日証協無担保0株0%1,200株-20%0株-100%
2017/04/21日証協有担保27,528株-5.12%1,000株-66.67%16,500株-68.87%
2017/04/14日証協無担保0株0%1,500株-71.15%500株-64.34%
2017/04/14日証協有担保29,014株-53.59%3,000株+76.47%53,000株+114.57%
2017/04/07日証協無担保0株0%5,200株0%1,402株-97.11%
2017/04/07日証協有担保62,517株-3.73%1,700株+1600%24,700株-78.41%
2017/03/31日証協無担保0株-100%0株-100%48,526株+9999.99%
2017/03/31日証協有担保64,940株+217.6%100株-99.9%114,400株+3072.49%
2017/03/24日証協無担保600株0%2,000株-96.64%400株-84%
2017/03/24日証協有担保20,447株-91.61%98,394株-20.29%3,606株-98.65%
2017/03/17日証協無担保0株-100%59,492株0%2,500株0%
2017/03/17日証協有担保243,710株+197.17%123,440株+606.1%267,230株+528.04%

※株式分割は考慮していませんのでご注意ください。

Page Top